BioSpace News Archive

Henry Schein, Inc. announced its presence at the 2023 Chicago Dental Society Midwinter meeting, featuring a comprehensive display of the Company’s expansive portfolio of products and solutions, designed to help oral health professionals enhance every aspect of their practice efficiency and the patient experience.

IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced a first-of-its-kind empirical study aimed at addressing veterinary practice capacity constraints.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced the upcoming presentation of new analyses of results from the SOLOIST-WHF Phase 3 outcomes study of its investigational sotagliflozin product at the American College of Cardiology’s 72nd Annual Scientific Session Together With World Heart Federation’s World Congress of Cardiology in New Orleans, Louisiana.

Olon Group and the Politecnico di Milano, Department of Chemistry, Materials and Chemical Engineering “Giulio Natta,” jointly announce an innovative public-private partnership agreement for a research project on the advanced study of polymorphism and the characterization of the solid state of the molecules of active ingredients.

Covalon Technologies Ltd. announced its participation for the first time in the Conference for Neonatology in Las Vegas, Nevada from Wednesday, February 22 to Friday, February 24, 2023.

IRLAB Therapeutics Gothenburg, Sweden, February 13, 2023 - IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that its CEO Richard Godfrey is leaving his position and that the Board of directors has appointed Gunnar Olsson as Interim CEO.

Medical Solutions, one of the largest healthcare talent ecosystems, today announced the promotion of two members of its senior leadership team.

Photocure ASA, The Bladder Cancer Company, announces the presentation of clinical data from the Veterans Affairs BRAVO study at the ASCO Genitourinary Cancers Symposium which was held February 16-18, 2023 in San Francisco, USA.

Medivir AB announced that the initial dose escalation part of the company’s 1b/2a study with the candidate drug fostroxacitabine bralpamide in hepatocellular carcinoma, in combination with Lenvima®, was successfully completed.

Medline announced it has entered a multi-year prime vendor partnership with Florida-based Synthase Collaborative, a partnership of four post-acute and home-based care organizations that provide not-for-profit hospice, palliative care, and other chronic Illness management community focused programs and services.